A predisposition to primary osteosarcoma development has been observed in patients presenting genetic abnormalities of the p53 tumour suppressor pathway (e.g., Li-Fraumeni-like syndrome) or retinoblastoma gene germline mutations. The gene discussed is TP53; the disease is Li-fraumeni-like syndrome.